AKE Stock Overview
Manufactures and sells specialty chemicals and advanced materials worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for AKE from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Arkema S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €72.10 |
| 52 Week High | €104.40 |
| 52 Week Low | €69.15 |
| Beta | 1.15 |
| 1 Month Change | -3.87% |
| 3 Month Change | -15.97% |
| 1 Year Change | -30.00% |
| 3 Year Change | -42.46% |
| 5 Year Change | -21.58% |
| Change since IPO | 123.57% |
Recent News & Updates
Take Care Before Diving Into The Deep End On Arkema S.A. (EPA:AKE)
Dec 23
At €75.00, Is It Time To Put Arkema S.A. (EPA:AKE) On Your Watch List?
Dec 02Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 09Recent updates
Take Care Before Diving Into The Deep End On Arkema S.A. (EPA:AKE)
Dec 23At €75.00, Is It Time To Put Arkema S.A. (EPA:AKE) On Your Watch List?
Dec 02Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 09Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality
Aug 08Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 05We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt
Jul 16Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year
May 13Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50
Apr 25Is Arkema (EPA:AKE) A Risky Investment?
Mar 29Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50
Mar 08Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 02Shareholder Returns
| AKE | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | 2.0% | 1.1% | 1.1% |
| 1Y | -30.0% | -4.9% | -3.5% |
Return vs Industry: AKE underperformed the French Chemicals industry which returned -4.9% over the past year.
Return vs Market: AKE underperformed the French Market which returned -3.5% over the past year.
Price Volatility
| AKE volatility | |
|---|---|
| AKE Average Weekly Movement | 3.5% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.4% |
Stable Share Price: AKE has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: AKE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 21,100 | Thierry Le Henaff | www.arkema.com |
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Arkema S.A. Fundamentals Summary
| AKE fundamental statistics | |
|---|---|
| Market cap | €5.45b |
| Earnings (TTM) | €346.00m |
| Revenue (TTM) | €9.49b |
15.7x
P/E Ratio0.6x
P/S RatioIs AKE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKE income statement (TTM) | |
|---|---|
| Revenue | €9.49b |
| Cost of Revenue | €7.55b |
| Gross Profit | €1.94b |
| Other Expenses | €1.60b |
| Earnings | €346.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 4.58 |
| Gross Margin | 20.45% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 59.1% |
How did AKE perform over the long term?
See historical performance and comparisonDividends
4.9%
Current Dividend Yield76%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 23:38 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arkema S.A. is covered by 38 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martin Schnee | AlphaValue |
| Andreas Heine | Barclays |
| James Stewart | Barclays |